rs1554310600
|
TMEM106B
|
LEUKODYSTROPHY, HYPOMYELINATING, 16
|
|
0.800 |
GeneticVariation |
UNIPROT |
The recurrent mutation in TMEM106B also causes hypomyelinating leukodystrophy in China and is a CpG hotspot.
|
29444210 |
2018 |
rs1554310600
|
TMEM106B
|
LEUKODYSTROPHY, HYPOMYELINATING, 16
|
A |
0.800 |
GeneticVariation |
CLINVAR |
The recurrent mutation in TMEM106B also causes hypomyelinating leukodystrophy in China and is a CpG hotspot.
|
29444210 |
2018 |
rs1554310600
|
TMEM106B
|
LEUKODYSTROPHY, HYPOMYELINATING, 16
|
|
0.800 |
GeneticVariation |
UNIPROT |
A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy.
|
29186371 |
2017 |
rs1554310600
|
TMEM106B
|
LEUKODYSTROPHY, HYPOMYELINATING, 16
|
A |
0.800 |
GeneticVariation |
CLINVAR |
A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy.
|
29186371 |
2017 |
rs1554310600
|
TMEM106B
|
LEUKODYSTROPHY, HYPOMYELINATING, 16
|
A |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs11509137
|
TMEM106B
|
Body Height
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs2043539
|
TMEM106B
|
Major Depressive Disorder
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions.
|
30718901 |
2019 |
rs10950393
|
TMEM106B
|
Major Depressive Disorder
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways.
|
29942085 |
2018 |
rs10950393
|
TMEM106B
|
Mood Disorders
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways.
|
29942085 |
2018 |
rs10950398
|
TMEM106B
|
Major Depressive Disorder
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.
|
29700475 |
2018 |
rs10950398
|
TMEM106B
|
Blood Protein Measurement
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Co-regulatory networks of human serum proteins link genetics to disease.
|
30072576 |
2018 |
rs11509880
|
TMEM106B
|
Coronary Artery Disease
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease.
|
29212778 |
2018 |
rs3173615
|
TMEM106B
|
High density lipoprotein measurement
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.
|
30275531 |
2018 |
rs3173615
|
TMEM106B
|
Triglycerides measurement
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.
|
30275531 |
2018 |
rs3807865
|
TMEM106B
|
Major Depressive Disorder
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways.
|
29662059 |
2018 |
rs3823612
|
TMEM106B
|
Major Depressive Disorder
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways.
|
29942085 |
2018 |
rs5011432
|
TMEM106B
|
Major Depressive Disorder
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways.
|
29662059 |
2018 |
rs7791726
|
TMEM106B
|
Frontotemporal dementia
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
|
29724592 |
2018 |
rs3173615
|
TMEM106B
|
Frontotemporal dementia
|
|
0.030 |
GeneticVariation |
BEFREE |
Recent studies found that two polymorphisms (rs363371 and rs363324) in VMAT2 might be a risk factor for Parkinson's disease (PD) in Caucasians, while the two other variants (rs1990622 and rs3173615) in TMEM106B increased the risk for frontotemporal dementia (FTD).
|
28477711 |
2017 |
rs3173615
|
TMEM106B
|
Frontotemporal dementia
|
|
0.030 |
GeneticVariation |
BEFREE |
The major allele of SNP rs3173615 is a risk factor in sporadic FTD, whereas the minor allele seems protective in GRN- and C9orf72-mediated FTD.
|
28888721 |
2017 |
rs3173615
|
TMEM106B
|
Frontotemporal dementia
|
|
0.030 |
GeneticVariation |
BEFREE |
TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
|
23742080 |
2013 |
rs3173615
|
TMEM106B
|
DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL
|
|
0.020 |
GeneticVariation |
BEFREE |
Eighty-six deceased male athletes with a history of participation in American football, informant-reported Caucasian, and a positive postmortem diagnosis of CTE without comorbid neurodegenerative disease were genotyped for rs3173615.
|
30390709 |
2018 |
rs3173615
|
TMEM106B
|
DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL
|
|
0.020 |
GeneticVariation |
BEFREE |
There were no significant differences in genetic variants for those with CTE pathology, but we observed a slight increase in MAPT H1 haplotype, and there tended to be fewer homozygous carriers of the protective TMEM106B rs3173615 minor allele in those with sports exposure and CTE pathology compared to those without CTE pathology.
|
26518018 |
2015 |
rs3173615
|
TMEM106B
|
Frontotemporal Lobar Degeneration
|
|
0.010 |
GeneticVariation |
BEFREE |
This variant is in high LD with the TMEM106B non-synonymous variant p.T185S (rs3173615; r<sup>2</sup> = 0.98) which was previously identified as a protective variant for frontotemporal lobar degeneration (FTLD).
|
31456032 |
2020 |
rs923630119
|
TMEM106B
|
Alzheimer Disease, Early Onset
|
|
0.010 |
GeneticVariation |
BEFREE |
In addition, a heterozygous p.Arg71Trp mutation in PSEN2 with an uncertain pathogenic nature was identified in a patient with neuropathologically confirmed AD.
|
31127772 |
2019 |